Does TRASTUZUMAB-QYYP Cause Cardiotoxicity? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Cardiotoxicity have been filed in association with TRASTUZUMAB-QYYP. This represents 1.6% of all adverse event reports for TRASTUZUMAB-QYYP.
5
Reports of Cardiotoxicity with TRASTUZUMAB-QYYP
1.6%
of all TRASTUZUMAB-QYYP reports
0
Deaths
2
Hospitalizations
How Dangerous Is Cardiotoxicity From TRASTUZUMAB-QYYP?
Of the 5 reports, 2 (40.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Cardiotoxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB-QYYP. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB-QYYP Cause?
Off label use (36)
Chills (33)
Nausea (32)
Diarrhoea (29)
Dyspnoea (24)
Infusion related reaction (24)
Vomiting (24)
Rash (18)
Death (17)
Headache (16)
What Other Drugs Cause Cardiotoxicity?
DOXORUBICIN (1,366)
CYCLOPHOSPHAMIDE (1,009)
TRASTUZUMAB (950)
VINCRISTINE (446)
FLUOROURACIL (425)
RITUXIMAB (389)
ETOPOSIDE (366)
CAPECITABINE (307)
TOCILIZUMAB (278)
PREDNISONE (277)
Which TRASTUZUMAB-QYYP Alternatives Have Lower Cardiotoxicity Risk?
TRASTUZUMAB-QYYP vs TRAVOPROST
TRASTUZUMAB-QYYP vs TRAZODONE
TRASTUZUMAB-QYYP vs TREANDA
TRASTUZUMAB-QYYP vs TREMELIMUMAB
TRASTUZUMAB-QYYP vs TREMELIMUMAB\TREMELIMUMAB-ACTL